| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $100.89M | - | |
| Dir | 1.55M | $79.76M | - | |
| Dir | 1.19M | $61.07M | - | |
| CFO | 1.12M | $57.37M | - | |
| VP | 594.7K | $30.54M | -43,451 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Wyszomierski Jack L | Director | Sale+OE | 8,768 | $37.80 | $331,430.40 | -2.4% | +10.1% | +13.9% | |
| Feb 28, 2025 | Smith Julie | Director | Sale+OE | 73,808 | $38.00 | $2,804,459.10 | -77.4% | +10.1% | +13.9% | |
| Feb 25, 2025 | Oliver Bob | Director | Sale+OE | 18,647 | $37.25 | $694,600.75 | -35.7% | +16.7% | +21.2% | |
| Feb 24, 2025 | Haley Patrick J.56 | EVP, Commercial | Sell | 52,636 | $36.98 | $1,946,479.28 | -14.8% | +16.1% | +21.6% | |
| Feb 24, 2025 | Aftab Dana | Cso/ EVP Disc &Trans Research | Sell | 26,987 | $36.75 | $991,772.25 | -5.0% | +16.1% | +21.6% | |
| Feb 24, 2025 | Senner Christopher J. | EVP And CFO | Sale+OE | 29,314 | $36.14 | $1,059,407.96 | -3.6% | +16.1% | +21.6% | |
| Feb 14, 2025 | Beckerle Mary C50 | Director | Sale+OE | 12,210 | $34.88 | $425,878.38 | -15.9% | +32.2% | +25.5% | |
| Feb 14, 2025 | Poste George | Director | Sale+OE | 15,874 | $34.74 | $551,462.76 | -8.6% | +32.2% | +25.5% | |
| Feb 14, 2025 | Eckhardt Sue Gail | Director | Sale+OE | 11,568 | $35.02 | $405,111.36 | -15.2% | +32.2% | +25.5% | |
| Feb 14, 2025 | Freire Maria C54 | Director | Sale+OE | 44,114 | $34.94 | $1,541,343.16 | -32.6% | +32.2% | +25.5% |